Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) General Information

Description

Portfolio of teralithe 250 mg, divisible tablet and teralithe lp 400 mg. The tablets consist of lithium carbonate.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Paris
  • France
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Acquirer
Corporate Office
  • Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg)‘s full profile, request access.

Request a free trial

Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg)‘s full profile, request access.

Request a free trial

Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) FAQs

  • Where is Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) headquartered?

    Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) is headquartered in Paris, France.

  • What industry is Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) in?

    Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg)’s primary industry is Buildings and Property.

  • Is Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) a private or public company?

    Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) is a Private company.

  • What is Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg)’s current revenue?

    The current revenue for Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) is .

  • Who are Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg)’s investors?

    Sanofi has invested in Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg).

  • When was Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) acquired?

    Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) was acquired on 31-Mar-2022.

  • Who acquired Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg)?

    Sanofi (Teralithe 250 Mg, Divisible Tablet And Teralithe Lp 400 Mg) was acquired by Delbert Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process